{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:00:38Z","timestamp":1784296838554,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":1506,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Ministero Italiano dell'Universit\u00e0 e della Ricerca","award":["7.07.02.60 AE01"],"award-info":[{"award-number":["7.07.02.60 AE01"]}]},{"name":"Progetti di Ricerca Finalizzata 2008"},{"name":"IRCCS Centro di Riferimento Oncologico della Basilicata","award":["7.07.08.60 P49"],"award-info":[{"award-number":["7.07.08.60 P49"]}]},{"name":"Progetto di Ricerca Sanitaria Finalizzata","award":["7.07.08.60 P51"],"award-info":[{"award-number":["7.07.08.60 P51"]}]},{"name":"Progetto di Ricerca Sanitaria Finalizzata","award":["RF-2009-1469205"],"award-info":[{"award-number":["RF-2009-1469205"]}]},{"name":"Progetto di Ricerca Sanitaria Finalizzata","award":["RF-2010-2307262"],"award-info":[{"award-number":["RF-2010-2307262"]}]},{"DOI":"10.13039\/100001253","name":"Multiple Myeloma Research Foundation","doi-asserted-by":"crossref","award":["GAP304\/10\/1395"],"award-info":[{"award-number":["GAP304\/10\/1395"]}],"id":[{"id":"10.13039\/100001253","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jmoldx.2015.05.007","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T21:05:23Z","timestamp":1440795923000},"page":"652-660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma"],"prefix":"10.1016","volume":"17","author":[{"given":"Daniela","family":"Drandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Kubiczkova-Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Dani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Passera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mantoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Gambella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Monitillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elona","family":"Saraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ghione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Genuardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Barbero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Omed\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Barberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Hajek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Vitolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Cortelazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Boccadoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ladetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2015.05.007_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/leu.2014.219","article-title":"Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival","volume":"29","author":"Ferrero","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.seminhematol.2011.05.002","article-title":"Minimal residual disease detection in mantle cell lymphoma: technical aspects and clinical relevance","volume":"48","author":"Pott","year":"2011","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1200\/JCO.2009.23.7172","article-title":"Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma","volume":"28","author":"Ladetto","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib4","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1182\/blood-2009-06-230250","article-title":"Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study","volume":"115","author":"Pott","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib5","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2013-06-507319","article-title":"Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program","volume":"122","author":"Ladetto","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib6","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1200\/JCO.2008.21.3116","article-title":"Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma","volume":"27","author":"Andersen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3324\/haematol.11267","article-title":"Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations","volume":"93","author":"B\u00f6ttcher","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib8","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1200\/JCO.2012.46.2119","article-title":"Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study","volume":"31","author":"Rawstron","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2011-07-370460","article-title":"High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma","volume":"119","author":"Paiva","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1083-8791(00)70006-1","article-title":"Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma","volume":"6","author":"Ladetto","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib11","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.leu.2401831","article-title":"Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR","volume":"14","author":"Br\u00fcggemann","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-62703-269-8_10","article-title":"MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR","volume":"971","author":"Pott","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbmt.2011.07.002","article-title":"The level of minimal residual disease in the bone marrow of patients with multiple myeloma before high-dose therapy and autologous blood stem cell transplantation is an independent predictive parameter","volume":"18","author":"Korthals","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/leu.2013.375","article-title":"Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders","volume":"28","author":"Ladetto","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib15","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1182\/blood-2014-01-550020","article-title":"Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma","volume":"123","author":"Martinez-Lopez","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib16","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1182\/blood-2008-05-159624","article-title":"Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation","volume":"112","author":"Paiva","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib17","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1182\/blood-2010-10-299487","article-title":"Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1","volume":"117","author":"Rajkumar","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib18","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1182\/blood.V78.12.3275.3275","article-title":"All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of BCL2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment","volume":"78","author":"Gribben","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","article-title":"Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib20","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/ac202578x","article-title":"Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification","volume":"84","author":"Pinheiro","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib21","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal Chem"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ymeth.2010.01.030","article-title":"High-throughput droplet PCR","volume":"50","author":"Markey","year":"2010","journal-title":"Methods"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1373\/clinchem.2014.221366","article-title":"Considerations for digital PCR as an accurate molecular diagnostic tool","volume":"61","author":"Huggett","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4939-0733-5_16","article-title":"Clinical applications using digital PCR","volume":"1160","author":"Bizouarn","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib25","doi-asserted-by":"crossref","first-page":"e85999","DOI":"10.1371\/journal.pone.0085999","article-title":"Comparison of droplet digital PCR and seminested real-time PCR for quantification of cell-associated HIV-1 RNA","volume":"9","author":"Kiselinova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/JCM.02620-12","article-title":"Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus","volume":"51","author":"Hayden","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jmoldx.2013.10.007","article-title":"Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR","volume":"16","author":"Jennings","year":"2014","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nmeth.2633","article-title":"Absolute quantification by droplet digital PCR versus analog real-time PCR","volume":"10","author":"Hindson","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib29","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1373\/clinchem.2013.214742","article-title":"Digital PCR as a novel technology and its potential implications for molecular diagnostics","volume":"59","author":"Huggett","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0301-472X(00)00651-2","article-title":"A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex\u00a0vivo purging in follicular lymphoma patients","volume":"29","author":"Ladetto","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2141.2012.09161.x","article-title":"Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leuc\u00e9mies et Autres Maladies du Sang","volume":"158","author":"Gimenez","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib32","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1373\/clinchem.2013.206375","article-title":"The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments","volume":"59","author":"Huggett","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib33","first-page":"716","article-title":"IMGT\/junctionanalysis: IMGT standardized analysis of the V-J and V-D-J junctions of the rearranged immunoglobulins (IG) and T cell receptors (TR)","volume":"2011","author":"Giudicelli","year":"2011","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib34","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib36","doi-asserted-by":"crossref","first-page":"e55943","DOI":"10.1371\/journal.pone.0055943","article-title":"Highly precise measurement of HIV DNA by droplet digital PCR","volume":"8","author":"Strain","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib37","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1021\/ac500208w","article-title":"Comparative study of sensitivity, linearity, and resistance to inhibition of digital and nondigital polymerase chain reaction and loop mediated isothermal amplification assays for quantification of human cytomegalovirus","volume":"86","author":"Nixon","year":"2014","journal-title":"Anal Chem"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib38","doi-asserted-by":"crossref","first-page":"11619","DOI":"10.1021\/ac403061n","article-title":"Multiplexed target detection using DNA-binding dye chemistry in droplet digital PCR","volume":"85","author":"McDermott","year":"2013","journal-title":"Anal Chem"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib39","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/ac403843j","article-title":"High sensitivity detection and quantitation of DNA copy number and single nucleotide variants with single color droplet digital PCR","volume":"86","author":"Miotke","year":"2014","journal-title":"Anal Chem"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib40","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1039\/c1lc20126c","article-title":"Multiplex digital PCR: breaking the one target per color barrier of quantitative PCR","volume":"11","author":"Zhong","year":"2011","journal-title":"Lab Chip"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib41","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1373\/clinchem.2013.211045","article-title":"Tolerance of droplet-digital PCR vs real-time quantitative PCR to inhibitory substances","volume":"59","author":"Dingle","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib42","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1373\/clinchem.2012.193409","article-title":"Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples","volume":"59","author":"Didelot","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.seminoncol.2011.11.009","article-title":"Acute lymphoblastic leukemia: monitoring minimal residual disease as a therapeutic principle","volume":"39","author":"Br\u00fcggemann","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jmoldx.2015.05.007_bib44","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood.V122.21.4293.4293","article-title":"Comparative Analysis Of Next-Generation Sequencing and Real-Time Quantitative PCR For Minimal Residual Disease Detection In Follicular Lymphomas","volume":"122","author":"Pott","year":"2013","journal-title":"Blood"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157815001476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157815001476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T22:45:22Z","timestamp":1576449922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157815001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1525157815001476"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2015.05.007","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2015.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}